NCT05612386View on ClinicalTrials.gov

Planning Message Recommending Same Time/Location as Last Vaccine

NACompletedINTERVENTIONAL
Enrollment

520,000

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

December 8, 2022

Study Completion Date

February 6, 2023

Conditions
COVID-19
Interventions
BEHAVIORAL

COVID Booster text messages

Participants will receive text messages per descriptions listed in the arms.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER